Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non-cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo

被引:36
|
作者
Vinay, K. [1 ]
Dogra, S. [1 ]
Parsad, D. [1 ]
Kanwar, A. J. [1 ]
Kumar, R. [1 ]
Minz, R. W. [2 ]
Saikia, U. N. [3 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Dermatol Venereol & Leprol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India
关键词
TRANSPLANTATION;
D O I
10.1111/jdv.12426
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundAutologous non-cultured outer root sheath hair follicle cell suspension (NCORSHFS) is a recently described novel cellular graft technique for the treatment of stable vitiligo. There is lack of data about various factors determining the repigmentation rate in vitiligo patients undergoing this novel surgical therapy. ObjectiveTo study the clinical characteristics and treatment variables determining therapeutic outcome in patients of stable vitiligo undergoing NCORSHFS. MethodsNon-cultured outer root sheath hair follicle cell suspension was prepared from anagen hairs extracted from the occipital area. The number of melanocytes and hair follicle stem cells (HFSC) in the suspension was quantified by staining with anti-HMB45 and anti-CD200 antibody, respectively. In all patients, a 2mm punch skin biopsy was taken from one of the vitiligo patch to be treated prior to surgery for assessment of histomorphological features. Post surgery patients were followed up at regular intervals for 24weeks. ResultsThirty patients (21 females, 9 males) with a clinical diagnosis of stable vitiligo, with a total of 60 target lesions were included in this study. The mean age of the study population was 21.105.64years. The number of melanocytes (P=0.04) and HFSC (P=0.01) transplanted were significantly higher among patients achieving optimum repigmentation (>75% repigmentation). There was a strong correlation between repigmentation at 24week and number of melanocytes and HFSC transplanted. Number of HFSC transplanted and absence of dermal inflammation were significant predictors of achieving optimum repigmentation. ConclusionThe number of melanocytes and HFSC transplanted and absence of dermal inflammation were important determents of optimal repigmentation in patients undergoing NCORSHFS for treatment of stable vitiligo. Hence, refining the technique of NCORSHFS on the basis of these factors would help in achieving better surgical outcomes.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 29 条
  • [21] Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo
    Ramos, Mariana Gontijo
    Ramos, Daniel Gontijo
    Ramos, Camila Gontijo
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (03) : 312 - 318
  • [22] Comparing the effect on the outcome of cold trypsinisation versus warm trypsinisation in transplantation of autologous non cultured epidermal cell suspension in stable vitiligo - a prospective randomized study
    Awasthi, S.
    Kanwar, A. J.
    Parsad, D.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 796 - 796
  • [23] EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION: CLINICAL IMPACT IN DIAGNOSIS, TREATMENT AND OUTCOME
    Roque, A.
    Pinto, A. L.
    Cortesao, E.
    Espadana, A. I.
    Sarmento-Ribeiro, A. B.
    Geraldes, C.
    Ribeiro, L.
    HAEMATOLOGICA, 2017, 102 : 531 - 532
  • [24] Clinical characteristics and treatment outcome of patients with advanced non-small-cell lung cancer (NSCLC) and FGFR fusions
    Scharpenseel, Heather
    Stickelmann, Andreas
    Siemanowski, Janna
    Malchers, Florian
    Scheffler, Matthias
    Hillmer, Axel
    Meemboor, Sonja
    Merkelbach-Bruse, Sabine
    Scheel, Andreas H.
    Riedel, Richard
    Friedrich, Sebastian Yves
    Eisert, Michels Anna
    Fischer, Rieke Nila
    Brodersen, Marlene
    Thomas, Roman K.
    Buettner, Reinhard
    Graeven, Ullrich
    Kosse, Nils
    Nogova, Lucia
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation
    K Weichman
    L M Dember
    T Prokaeva
    D G Wright
    K Quillen
    M Rosenzweig
    M Skinner
    D C Seldin
    V Sanchorawala
    Bone Marrow Transplantation, 2006, 38 : 339 - 343
  • [26] Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation
    Weichman, K.
    Dember, L. M.
    Prokaeva, T.
    Wright, D. G.
    Quillen, K.
    Rosenzweig, M.
    Skinner, M.
    Seldin, D. C.
    Sanchorawala, V.
    BONE MARROW TRANSPLANTATION, 2006, 38 (05) : 339 - 343
  • [27] Treatment outcome and clinical characteristics of HER2 mutated advanced non-small cell lung cancer patients in China
    Xu, Fei
    Yang, Guangjian
    Xu, Haiyan
    Yang, Lu
    Qiu, Weini
    Wang, Yan
    THORACIC CANCER, 2020, 11 (03) : 679 - 685
  • [28] Clinical characteristics and treatment outcome of FGFR1-3 fusions in patients with non-small cell lung cancer (NSCLC): A multicenter analysis from National Network Genomic Medicine
    Stickelmann, A.
    Scharpenseel, H.
    Siemanowski, J.
    Malchers, F.
    Terjung, I
    Hillmer, A.
    Meemboor, S.
    Mrkelbach-Bruse, S.
    Scheel, A. H.
    Woempner, C.
    Scheffler, M.
    Riedel, R.
    Michels, S.
    Eisert, A.
    Fischer, R. N.
    Ruge, L.
    John, F.
    Passmann, E.
    Brodersen, M.
    Blum, T. G.
    Stephan-Falkenau, S.
    Kosse, N.
    Saalfeld, F.
    Tritchkova, G.
    Schubart, C.
    Toegel, L.
    Thielert, Noelle F.
    Wiesweg, M.
    Braeuninger, A.
    Eul, B.
    Althoff, F. C.
    Demes, M.
    Stenzinger, A.
    Christopoulos, P.
    Graeven, U.
    Berezucki, E.
    Konstandin, N. P.
    Stilgenbauer, S.
    Ruecker, F.
    Kulhavy, J.
    Hummel, H. -D
    Buettner, R.
    Wolf, J.
    Nogova, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 146 - 147
  • [29] Association between clinical characteristics and treatment outcome of immune checkpoint inhibitor with or without chemotherapy in elderly non-small cell lung cancer patients with high PD-L1 expression
    Kawachi, Hayato
    Takei, Shota
    Yamada, Tadaaki
    Tamiya, Motohiro
    Negi, Yoshiki
    Goto, Yasuhiro
    Nakao, Akira
    Shiotsu, Shinsuke
    Takeda, Takayuki
    Okada, Asuka
    Harada, Taishi
    Date, Koji
    Chihara, Yusuke
    Hasegawa, Isao
    Tamiya, Nobuyo
    Kijima, Takashi
    Takayama, Koichi
    CANCER RESEARCH, 2024, 84 (06)